Centre Hospitalier Le Mans

Le Mans, Sarthe 72037

1 studies enrolling now · 9 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hidradenitis Suppurativa, Leukemia, Myeloid, Acute, Melanoma, Newly Diagnosed Acute Myeloid Leukemia (AML), Plaque Psoriasis, Refractory Follicular Lymphoma, Relapsed and/or Refractory Multiple Myeloma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Zasocitinib in Adults With Hidradenitis Suppurativa — Recruiting now
• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients — Running, not enrolling
• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed